PTHLH and neoplasm: The qRT-PCR assay demonstrated that, among renal tumor subtypes, the clear cell RCCs presented with a higher incidence of detectable signals of PTHLH (535/542 tumors; 98.7%) compared to the other tumor subtypes (60.5–83.3%) as well as to normal kidney samples (58.8%) (Fig.1B).